Jason Bassetti

Davis Polk advised Acutus Medical, Inc. on its SEC-registered initial public offering of 10,147,058 shares of common stock for an aggregate price to the public of approximately $170 million…

Davis Polk advised the joint book-running managers on an SEC-registered debt offering by Alphabet Inc., consisting of $1 billion of 0.450% notes due 2025, $1 billion of 0.800% notes…

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by CryoLife, Inc. of $100 million aggregate principal amount of its 4.250% convertible senior notes due 2025…

Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…

Davis Polk advised Credo Technology Group Holding Ltd on its private placement of approximately $100 million in shares of its Series D preferred stock. Credo is a leading provider of high…

Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 865,963 shares of common stock for an aggregate price to the public of approximately $143.75 million,…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …

Davis Polk advised McKesson Corporation in connection with the offer by McKesson to exchange shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock owned by…

Davis Polk advised Shockwave Medical, Inc. in connection with a $16.5 million supplemental term loan provided by Silicon Valley Bank. Shockwave Medical used a portion of the proceeds…

Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 2,481,781 shares of common stock for an aggregate price to the public of approximately $90 million. The…